Han, Han https://orcid.org/0000-0003-2222-5270
Huang, Zhen
Xu, Congsheng
Seo, Gayoung
An, Jeongmin https://orcid.org/0000-0002-2357-0941
Yang, Bing
Liu, Yuhan
Lan, Tian
Yan, Jiachen
Ren, Shanshan
Xu, Yue
Xiao, Di
Yan, Jonathan K.
Ahn, Claire
Fishman, Dmitry A. https://orcid.org/0000-0001-6287-2128
Meng, Zhipeng https://orcid.org/0000-0003-4756-6303
Guan, Kun-Liang https://orcid.org/0000-0003-1892-0174
Qi, Ruxi
Luo, Ray https://orcid.org/0000-0002-6346-8271
Wang, Wenqi https://orcid.org/0000-0003-4053-5088
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM126048)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM143233)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM130367)
American Cancer Society (RSG-18-009-01-CCG)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54CA217378)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA062203)
National Natural Science Foundation of China (32370766)
National Natural Science Fund for Excellent Young Scientists Fund Program
Article History
Received: 5 February 2024
Accepted: 12 November 2024
First Online: 21 November 2024
Competing interests
: K.-L.G. is a co-founder of and holds an equity interest in Vivace Therapeutics. The other authors declare no competing interests.